Nerivio: Key things to know about drug-free cure for migraine

“Nerivio® is the first and only USFDA approved device to use Remote Electrical Neuromodulation (REN) to…

Diwali 2023 Picks: Reliance, Dr Reddy’s among top 10 buys from HDFC Securities

The Nifty Smallcap 100 and Nifty Midcap 100 indices rallied 28% and 26%, respectively. Among sectors,…

Dr Reddy’s eyes a gradual recovery after a weak quarter

Shares of Dr Reddy’s Laboratories Ltd emerged as the top loser among Nifty 50 companies on…

Dr Reddy’s acquires US generic portfolio of Mayne Pharma for $105 million

Symbolic picture only. , Photo Credit: Special Arrangement Dr Reddy’s Laboratories (DRL) is acquiring the US…

Sun, Cipla’s US show tops Dr Reddy’s, Lupine in Q1

New Delhi The June quarter results of the four big pharma companies have recently shown the…

Motilal Oswal S&P BSE Healthcare ETF NFO Open for Membership

Motilal Oswal Mutual Fund’s Motilal Oswal S&P BSE Healthcare ETF is now open for subscription. It…

Stocks to watch today: Zomato, Axis Bank, Dr Reddy’s Laboratories, and others

nifty Futures on the Singapore Exchange were trading 162.5 points or 1.03 per cent higher at…

Dr Reddy’s raised $72m. Dispute settled with IndieWire to receive

As part of the settlement, the underlying litigation will be dismissed, the Hyderabad-headquartered drugmaker said. As…

Pharma major Dr Reddy’s plans for ‘business continuity’ in Russia – Times of India

New Delhi: Pharmaceutical major Dr Reddy’s Laboratories Ltd. said on Wednesday it was focused on employee…